Article Versions Notes

Amon R, Rosenfeld R, Perlmutter S, Grant OC, Yehuda S, Borenstein-Katz A, Alcalay R, Marshanski T, Yu H, Diskin R, et al. Directed Evolution of Therapeutic Antibodies Targeting Glycosylation in Cancer. Cancers. 2020; 12(10):2824. https://doi.org/10.3390/cancers12102824

Amon, Ron, Ronit Rosenfeld, Shahar Perlmutter, Oliver C. Grant, Sharon Yehuda, Aliza Borenstein-Katz, Ron Alcalay, Tal Marshanski, Hai Yu, Ron Diskin, and et al. 2020. "Directed Evolution of Therapeutic Antibodies Targeting Glycosylation in Cancer" Cancers 12, no. 10: 2824. https://doi.org/10.3390/cancers12102824

Amon, R., Rosenfeld, R., Perlmutter, S., Grant, O. C., Yehuda, S., Borenstein-Katz, A., Alcalay, R., Marshanski, T., Yu, H., Diskin, R., Woods, R. J., Chen, X., & Padler-Karavani, V. (2020). Directed Evolution of Therapeutic Antibodies Targeting Glycosylation in Cancer. Cancers, 12(10), 2824. https://doi.org/10.3390/cancers12102824